EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by 1H-NMR. A real-world observational study (IPE-NMR)

Núria Amigó, Ernesto Dalli-Peydró, José Luis Díaz-Díaz, Armando Oterino, Lydia Cabau, Jara Ballestín-Ballestín, Xavier Garcia-Moll, Lluís Masana, IPE-NMR study group

Nutrition, Metabolism and Cardiovascular Diseases · 2026

DOI: 10.1016/j.numecd.2026.104852 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Núria Amigó und 8 weiteren Autor:innen. Beteiligte Einrichtung: Reus Lipid RDI Cluster (LIRIC-BIOSFERTESLAB), Universitat Rovira i Virgili, IRB CatSud, CIBERDEM, Reus, Spain. Hauptthemen laut MEDLINE: Atherosclerosis, Dyslipidemias, Eicosapentaenoic Acid, Glycoproteins. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Icosapent-ethyl (IPE) has been shown to reduce cardiovascular events in a randomized trial; however, its real-world impact on advanced lipoprotein and inflammatory profiles remains incompletely characterized. We evaluated the effects of IPE on lipoprotein particle number, size, composition, and circulating glycoproteins using proton nuclear magnetic resonance (1H-NMR) spectroscopy in real-world clinical practice. METHODS AND RESULTS: This multicentre, prospective, open-label observational study included patients with established atherosclerotic cardiovascular disease receiving IPE 2 g twice daily for ≥4 months in addition to optimized lipid-lowering therapy. Lipoprotein subclasses and Glyc acetyl signals were quantified by 1H-NMR at baseline and follow-up. Changes were assessed using paired statistical tests, and analyses were stratified according to tertiles of triglyceride (TG) response. Sixty-two patients completed paired NMR assessments. Mean age was 64 years, 17.7% were women, median baseline LDL-cholesterol was 1.50 (1.09-1.82) mmol/L, and median TG concentration was 2.35 mmol/L (2.01-3.16). Overall TG levels decreased with substantial interindividual variability; tertiles 2 and 3 showed mean TG reductions of -21.6% and -38%, respectively, while tertile 1 were non-responders (less than 10% TG reduction). In responders, IPE therapy significantly reduced triglyceride-rich lipoprotein particles, particularly small VLDL remnants, as well as remnant cholesterol and small LDL particles. HDL triglyceride content was also reduced. The Glyc acetyl were also significantly reduced, indicating decreased systemic inflammation. CONCLUSIONS: In a real-world secondary prevention population, IPE therapy significantly improved atherogenic lipoprotein profiles and inflammatory biomarkers, supporting its role in reducing residual cardiovascular risk beyond triglyceride lowering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisDyslipidemiasEicosapentaenoic AcidGlycoproteinsHypolipidemic AgentsLipoproteinsProton Magnetic Resonance SpectroscopyAgedFemaleHumansMaleMiddle AgedBiomarkersProspective StudiesTime FactorsTreatment OutcomeTriglycerides

Stichwörter der Autor:innen

Cardiovascular preventionGlycoproteinsHigh triglyceridesIcosapent ethylLipoprotein particle numberNMR lipoprotein profileReduce-it trial

Substanzen

BiomarkersEicosapentaenoic Acideicosapentaenoic acid ethyl esterGlycoproteinsHypolipidemic AgentsLipoproteinsTriglycerides

Autor:innen und Institutionen

  • Reus Lipid RDI Cluster (LIRIC-BIOSFERTESLAB), Universitat Rovira i Virgili, IRB CatSud, CIBERDEM, Reus, Spain.
  • Servicio de Cardiología, Hospital Arnau de Vilanova de Valencia, Unidad de Telerrehabilitación Cardiaca, Spain.
  • Unidad de Lípidos y Riesgo Cardiovascular, Servicio de Medicina Interna, Complejo Hospitalario Unversitario de A Coruña, A Coruña, Spain.
  • Cardiology Department, Hospital Universitario San Pedro de Alcántara, Cáceres, Spain.
  • Servei Cardiologia, Hospital Universitari Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Reus Lipid RDI Cluster (LIRIC-URLA), Universitat Rovira i Virgili, IRB CatSud. CIBERDEM, Reus, Spain. Electronic address: luis.masana@urv.cat.

Zitieren

APA

Amigó, N., Dalli-Peydró, E., Díaz-Díaz, J. L., Oterino, A., Cabau, L., Ballestín-Ballestín, J., Garcia-Moll, X., Masana, L., & IPE-NMR study group (2026). Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by 1H-NMR. A real-world observational study (IPE-NMR). Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2026.104852

Vancouver

Amigó N, Dalli-Peydró E, Díaz-Díaz JL, Oterino A, Cabau L, Ballestín-Ballestín J, et al. Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by 1H-NMR. A real-world observational study (IPE-NMR). Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2026.104852

BibTeX
@article{Amig2026,
  author = {Amigó, Núria and Dalli-Peydró, Ernesto and Díaz-Díaz, José Luis and Oterino, Armando and Cabau, Lydia and Ballestín-Ballestín, Jara and Garcia-Moll, Xavier and Masana, Lluís and IPE-NMR study group, IPE-NMR study group},
  title = {Impact of icosapent ethyl on serum lipoand glycoprotein profiles assessed by 1H-NMR. A real-world observational study (IPE-NMR)},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.numecd.2026.104852}
}
Kostenlos starten →